BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06772623-completion@plaintrial.com
DTSTAMP:20261027T153832Z
DTSTART;VALUE=DATE:202711
SUMMARY:Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) T
 elisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhib
 itor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC 
 With No Prior Treatment for Advanced Disease\, and No Actionable Genomic A
 lterations — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06772623
URL:https://plaintrial.com/trial/NCT06772623
END:VEVENT
END:VCALENDAR